134 related articles for article (PubMed ID: 37068594)
1. Predictors of recurrence of cancer-associated venous thromboembolism after discontinuation of anticoagulant therapy: a multicenter cohort study.
Lapébie FX; Bura-Rivière A; Espitia O; Bongard V; Ciammaichella MM; Martínez JG; Sigüenza P; Giménez JC; Bertoletti L; Monreal M
J Thromb Haemost; 2023 Aug; 21(8):2189-2201. PubMed ID: 37068594
[TBL] [Abstract][Full Text] [Related]
2. Venous Thromboembolism Recurrence in Latvian Population: Single University Hospital Data.
Ģībietis V; Kigitoviča D; Strautmane S; Meilande K; Kalējs VR; Zaičenko A; Maķe K; Lejnieks A; Skride A
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31438542
[No Abstract] [Full Text] [Related]
3. Risk of cancer after anticoagulation in patients with unprovoked venous thromboembolism: an observational cohort study.
Eischer L; Kammer M; Traby L; Kyrle PA; Eichinger S
J Thromb Haemost; 2017 Jul; 15(7):1368-1374. PubMed ID: 28407356
[TBL] [Abstract][Full Text] [Related]
4. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
[TBL] [Abstract][Full Text] [Related]
5. Treatment of DVT: how long is enough and how do you predict recurrence.
Agnelli G; Becattini C
J Thromb Thrombolysis; 2008 Feb; 25(1):37-44. PubMed ID: 17906973
[TBL] [Abstract][Full Text] [Related]
6. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE Registry.
Barillari G; Londero AP; Brenner B; Nauffal D; Muñoz-Torrero JF; Del Molino F; Moustafa F; Madridano O; Martín-Martos F; Monreal M;
Eur J Intern Med; 2016 Jul; 32():53-9. PubMed ID: 26972931
[TBL] [Abstract][Full Text] [Related]
8. Outcomes Associated With Inferior Vena Cava Filters Among Patients With Thromboembolic Recurrence During Anticoagulant Therapy.
Mellado M; Pijoan JI; Jiménez D; Muriel A; Aujesky D; Bertoletti L; Decousus H; Barrios D; Clará A; Yusen RD; Monreal M;
JACC Cardiovasc Interv; 2016 Dec; 9(23):2440-2448. PubMed ID: 27838262
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and Safety of Direct Oral Anticoagulants vs. Warfarin and Recurrence After Discontinuation in Patients With Acute Venous Thromboembolism in the Real World.
Hara N; Lee T; Nozato T; Terui Matsuyama M; Okata S; Nagase M; Mitsui K; Nitta G; Watanabe K; Miyazaki R; Nagamine S; Kaneko M; Nakamura T; Nagata Y; Miyamoto T; Obayashi T; Ashikaga T
Circ J; 2022 May; 86(6):923-933. PubMed ID: 34645732
[TBL] [Abstract][Full Text] [Related]
10. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
11. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism.
Douketis JD; Gu CS; Schulman S; Ghirarduzzi A; Pengo V; Prandoni P
Ann Intern Med; 2007 Dec; 147(11):766-74. PubMed ID: 18056660
[TBL] [Abstract][Full Text] [Related]
12. Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study.
Blondon M; Jimenez D; Robert-Ebadi H; Del Toro J; Lopez-Jimenez L; Falga C; Skride A; Font L; Vazquez FJ; Bounameaux H; Monreal M;
J Thromb Haemost; 2021 Feb; 19(2):408-416. PubMed ID: 33119949
[TBL] [Abstract][Full Text] [Related]
13. The risk of recurrence in women with venous thromboembolism while using estrogens: a prospective cohort study.
Eischer L; Eichinger S; Kyrle PA
J Thromb Haemost; 2014 May; 12(5):635-40. PubMed ID: 24548536
[TBL] [Abstract][Full Text] [Related]
14. Risk of recurrent cancer-associated thrombosis after discontinuation of anticoagulant therapy.
Barca-Hernando M; Lopez-Ruz S; Marin-Romero S; Garcia-Garcia V; Elias-Hernandez T; Otero-Candelera R; Carrier M; Jara-Palomares L
Res Pract Thromb Haemost; 2023 Feb; 7(2):100115. PubMed ID: 37063761
[TBL] [Abstract][Full Text] [Related]
15. Tinzaparin and VKA use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
Noel-Savina E; Sanchez O; Descourt R; André M; Leroyer C; Meyer G; Couturaud F
Thromb Res; 2015 Jan; 135(1):78-83. PubMed ID: 25466839
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcomes of Incidental Venous Thromboembolism in Cancer and Noncancer Patients: The SWIss Venous ThromboEmbolism Registry (SWIVTER).
Spirk D; Sebastian T; Barco S; Banyai M; Beer JH; Mazzolai L; Baldi T; Aujesky D; Hayoz D; Engelberger RP; Kaeslin T; Korte W; Escher R; Husmann M; Blondon M; Kucher N
Thromb Haemost; 2021 May; 121(5):641-649. PubMed ID: 33202448
[TBL] [Abstract][Full Text] [Related]
17. Cohort Study on the Management of Cancer-Associated Venous Thromboembolism Aimed at the Safety of Stopping Anticoagulant Therapy in Patients Cured of Cancer.
van der Hulle T; den Exter PL; van den Hoven P; van der Hoeven JJ; van der Meer FJ; Eikenboom J; Huisman MV; Klok FA
Chest; 2016 May; 149(5):1245-51. PubMed ID: 26836911
[TBL] [Abstract][Full Text] [Related]
18. The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysis.
van Hylckama Vlieg MAM; Nasserinejad K; Visser C; Bramer WM; Ashrani AA; Bosson JL; Crusan DJ; D'Alessio A; Fluharty ME; Ģībietis V; Hansson PO; Hara N; Jara-Palomares L; Kraaijpoel N; Mahé I; Marshall A; Ogino Y; Otero R; Versmissen J; Klok FA; Kruip MJHA; van der Rijt CCD; Geijteman ECT
EClinicalMedicine; 2023 Oct; 64():102194. PubMed ID: 37731937
[TBL] [Abstract][Full Text] [Related]
19. Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registry.
Alatri A; Mazzolai L; Font C; Tafur A; Valle R; Marchena PJ; Ballaz A; Tiraferri E; Font L; Monreal M; Riete Investigators T
Thromb Haemost; 2017 Jul; 117(8):1630-1636. PubMed ID: 28517021
[TBL] [Abstract][Full Text] [Related]
20. Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study.
Noumegni SR; Didier R; Mansourati V; Tromeur C; Le Moigne E; Hoffmann C; Nasr B; Gentric JC; Guegan M; Poulhazan E; Lacut K; Bressollette L; Le Mao R; Couturaud F
Thromb Res; 2022 Jun; 214():93-105. PubMed ID: 35525202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
